The legacy success of sildenafil has undeniably transformed the drug landscape. However, wagering in companies heavily focused on biosimilars and the waning patent exclusivity surrounding this iconic https://poppyjymf748637.newsbloger.com/41603398/the-blue-pill-and-pharmaceutical-companies-a-risky-opportunity